Karen Kelly, M.D.
- Associate Director for Clinical Research, UC Davis Comprehensive Cancer Center
- Jennifer Rene Harmon Tegley and Elizabeth Erica Harmon Endowed Chair in Cancer Clinical Research
- Professor of Medicine
Dr. Kelly is an internationally recognized lung cancer expert dedicated to providing enhanced cancer care through cutting-edge clinical trials. Dr. Kelly’s lung cancer research spans the spectrum of the disease from prevention to treatment. She has been at the forefront of clinical trials development evaluating drugs to treat lung cancer and novel compounds to prevent lung cancer. She is also involved in developing biomarkers for screening and early detection of lung cancer. Dr. Kelly has authored or co-authored more than 190 publications, including original papers, reviews and book chapters. She frequently lectures on lung cancer topics, nationally and internationally. Dr. Kelly is a long-standing active member of ASCO, SWOG and the IASLC.
Hematology and Oncology
M.D., University of Kansas School of Medicine, Kansas City, Kansas, 1984
B.S., Emporia State University, Emporia, Kansas, 1978
University of Colorado Health Sciences Center, Denver, Colorado, 1987
University of Colorado Health Sciences Center, Denver, Colorado, 1990
American Board of Internal Medicine, 1987
American Board of Internal Medicine, Medical Oncology, 2013
American Association for Canter Research (AACR)
International Association for the Study of Lung Cancer (IASLC)
Southwest Oncology Group (SWOG)
Honors and Awards
Sacramento Magazine Top Doctors, 2011
Fellow, Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) Program for Women, 2012
Fellow, American Society of Clinical Oncology (FASCO), 2012
Kansas City Business Journal Best Doctors in Kansas City, 2010
Glasgow Memorial Achievement Citation for Scholastic Achievement, 1984
Alpha Omega Alpha Honor Medical Society, 1983
Select Recent Publications
For a comprehensive list of Dr. Kelly's publications, please click here (opens new window).